XML 53 R17.htm IDEA: XBRL DOCUMENT v3.20.1
Equity Incentive Plans
12 Months Ended
Dec. 31, 2019
Equity Incentive Plans  
Equity Incentive Plans

10.           Equity Incentive Plans

2019 Equity Incentive Plan

The Company’s board of directors adopted and our stockholders approved our 2019 Equity Incentive Plan, (the “2019 Plan”), on June 2, 2019, and June 7, 2019, respectively. The 2019 Plan became effective on June 19, 2019, and no further grants will be made under the Company’s 2010 Equity Incentive Plan. The purpose of the 2019 Plan, through the grant of stock awards including stock options and other stock-based awards, including restricted stock units (“RSUs”), is to help us secure and retain the services of eligible award recipients, provide incentives for such persons to exert maximum efforts for our success and that of our affiliates, and provide a means by which the eligible recipients may benefit from increases in the value of our Class A common stock. Under the 2019 Plan, 6,141,842 shares of the Company’s Class A common stock have been reserved for issuance to employees, directors and consultants. Additionally, the number of shares of our Class A common stock reserved for issuance under our 2019 Plan will automatically increase on January 1 of each year, beginning on January 1, 2020 and continuing through and including January 1, 2029, by 4% of the total number of shares of our capital stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares determined by our board of directors.

Stock option activity under the Plan is as follow (in thousands, except share and per share data and years):

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

 

 

 

 

 

 

Weighted-

 

 

 

 

 

 

 

 

 

 

Average

 

Aggregate

 

 

 

 

Weighted-

 

Remaining

 

Intrinsic

 

 

Number

 

Average

 

Contractual

 

Value

 

    

of Shares

 

Exercise Price

 

Life (years)

 

(in thousands)

Balances, December 31, 2017

 

567,319

 

$

3.96

 

8.1

 

$

694

Granted

 

1,609,086

 

 

6.66

 

 

 

 

 

Exercised

 

(27,832)

 

 

1.68

 

 

 

 

 

Cancelled

 

(12,282)

 

 

4.92

 

 

 

 

 

Balances, December 31, 2018

 

2,136,291

 

$

6.06

 

8.9

 

$

12,881

Granted

 

1,764,713

 

 

13.63

 

 

 

 

 

Exercised

 

(77,368)

 

 

3.94

 

 

 

 

 

Cancelled

 

(81,492)

 

 

9.80

 

 

 

 

 

Balances, December 31, 2019

 

3,742,144

 

$

9.58

 

8.6

 

$

22,910

Vested and expected to vest at December 31, 2019

 

3,742,144

 

$

9.58

 

8.6

 

$

22,910

Exercisable at December 31, 2019

 

1,793,254

 

$

5.87

 

7.7

 

$

17,211

Vested at December 31, 2019

 

1,168,118

 

$

6.27

 

7.5

 

$

10,747

 

Additional information regarding the Company’s stock options outstanding and vested and exercisable as of December 31, 2019 is summarized below:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding

 

Options Exercisable

 

    

 

    

Weighted-

    

 

    

 

    

 

 

 

 

 

Average

 

 

 

 

 

Weighted-

 

 

 

 

Remaining

 

Weighted-

 

 

 

Average

 

 

Number of

 

Contractual

 

Average

 

Shares Subject

 

Exercise 

 

 

Stock Options

 

Life

 

Exercise Price

 

to Stock

 

Price per

Exercise Prices

 

Outstanding

 

(Years)

 

per Share

 

Options

 

Share

Up to $0.66

 

48,984

 

2.9

 

$

0.17

 

48,984

 

$

0.17

$4.56-$5.16

 

1,474,367

 

7.7

 

$

5.00

 

1,450,561

 

$

5.00

$9.94-$12.95

 

1,720,981

 

9.1

 

$

11.56

 

293,709

 

$

11.13

$16.10-$22.06

 

497,812

 

9.5

 

$

17.18

 

 —

 

 

 —

 

 

3,742,144

 

8.6

 

$

9.58

 

1,793,254

 

$

5.87

 

 

The weighted‑average grant date fair value of options granted to employees and non‑employees in the year ended December 31, 2019 and 2018 was $10.35 and $5.16, respectively. The fair value of each option is estimated on the date of grant using the Black‑Scholes option pricing model, assuming no expected dividends and the following weighted average assumptions:

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

 

 

    

2019

    

2018

 

 

Expected life (in years)

 

6.02

 

6.01

 

 

Volatility

 

81.0

%  

78.3

%

 

Risk-free interest rate

 

2.16

%  

2.88

%

 

 

Expected volatility is based on volatilities of public companies operating in the Company’s industry. The expected life of the options is estimated using the simplified method detailed in SEC Staff Accounting Bulletin No. 107. The simplified method calculates the expected term as the mid-point between the weighted-average time to vesting and the contractual maturity. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant. The Company has elected to account for forfeitures as they occur, rather than estimate expected forfeitures.

2019 Employee Stock Purchase Plan

The Company’s board of directors adopted the 2019 Employee Stock Purchase Plan, (“ESPP”), on June 2, 2019, and the Company’s stockholders approved the ESPP on June 7, 2019. The ESPP became effective on June 19, 2019. The Company’s board of directors authorized 283,333 shares of Class A common stock to be reserved for future issuance under the ESPP. The number of shares of our Class A common stock reserved for issuance will automatically increase on January 1 of each calendar year, from January 1, 2020 through January 1, 2029, by the lesser of (1) 1% of the total number of shares of our Class A common stock outstanding on December 31 of the preceding calendar year, and (2) 416,666 shares; provided, that prior to the date of any such increase, the Company’s board of directors may determine that such increase will be less than the amount set forth in clauses (1) and (2). During the year ended December 31, 2019, the expense related to the ESPP was $348,000.  The fair value of each ESPP is estimated on the date of grant using the Black‑Scholes option pricing model, assuming no expected dividends and the following range of assumptions:

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

 

    

2019

    

2018

 

Expected life (in years)

 

0.2 - 2.0

 

 —

 

Volatility

 

74.5 - 101.6

%  

 —

%

Risk-free interest rate

 

1.50 - 2.15

%  

 —

%

 

The Company recognized $6.1 million and $1.4 million of stock‑based compensation expense related to options and the ESPP granted to employees and non‑employees for the years ended December 31, 2019 and 2018, respectively. The compensation expense is allocated on a departmental basis, based on the classification of the option holder as follows (in thousands):

 

 

 

 

 

 

 

 

 

 

Year Ended December 31, 

 

 

    

2019

    

2018

 

Research and development

 

$

2,977

 

$

631

 

General and administrative

 

 

3,079

 

 

788

 

 

 

$

6,056

 

$

1,419

 

 

No income tax benefits have been recognized in the statements of operations for stock‑based compensation arrangements and no stock‑based compensation costs have been capitalized as property and equipment as of December 31, 2019.

Unrecognized estimated compensation expense as of December 31, 2019, totaled $20.0 million related to non‑vested stock options with a remaining requisite service period of 3.1 years.